Moberg Pharma's nomination committee appointed
- Gillis Cullin, appointed by Östersjöstiftelsen
- Fredrik Åsberg
- Martin Öhrn, appointed by Anders Lundmark
- Kerstin Valinder Strinnholm, Chairman of the Board
Together, the Nomination Committee represents 12.6 percent of the shares in Moberg Pharma as of September 30[th], 2022.
The Nomination Committee shall submit proposals for the fiscal year January - December 2022 by the Annual General Meeting pertaining to the election of Chairman of the Board, fees and composition of the Board, auditors' fees and the election of auditors.
The Annual General Meeting for the fiscal year January - December 2022 will be held on May 16[th] 2023.
Shareholders wishing to submit proposals to Moberg Pharma's Nomination Committee can do so by e-mail to info@mobergpharma.seby March 28[th], 2023.
About this information
The information was submitted for publication, through the agency of the contact person set out below, at 8.30 a.m. CET on November 3[rd], 2022.